ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 199 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $10,163,000 | -43.5% | 143,481 | -31.8% | 1.28% | -54.1% |
| Q3 2018 | $17,981,000 | -35.2% | 210,400 | -74.6% | 2.80% | -50.8% |
| Q4 2016 | $27,746,000 | +32.0% | 828,253 | +4.8% | 5.70% | +6.3% |
| Q3 2016 | $21,022,000 | +77.2% | 790,000 | +46.8% | 5.36% | +57.8% |
| Q2 2016 | $11,863,000 | +653.2% | 538,024 | +1437.2% | 3.40% | +453.3% |
| Q2 2015 | $1,575,000 | -48.6% | 35,000 | -65.0% | 0.61% | -54.5% |
| Q1 2015 | $3,062,000 | – | 100,000 | – | 1.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 1,055,719 | $35,367,000 | 12.68% |
| GREAT POINT PARTNERS LLC | 828,253 | $27,746,000 | 5.70% |
| McClain Value Management LLC | 116,153 | $3,891,000 | 4.80% |
| Stonepine Capital Management, LLC | 231,913 | $7,769,000 | 4.63% |
| ARMISTICE CAPITAL, LLC | 228,000 | $7,638,000 | 1.81% |
| Opaleye Management Inc. | 90,000 | $3,015,000 | 1.78% |
| Matarin Capital Management, LLC | 257,268 | $8,618,478,000 | 0.97% |
| HAYS ADVISORY LLC | 116,939 | $3,917,000 | 0.87% |
| Granahan Investment Management | 496,025 | $16,617,000 | 0.57% |
| AlphaMark Advisors, LLC | 33,000 | $1,106,000 | 0.57% |